Validity of a single-item indicator of treatment side effect bother in patients with head and neck cancer.

Laila A GharzaiMichelle L MierzwaKatelyn O StepanDavid CellaJohn Devin Peipert

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)

GP5 exhibited validity within HNSCC, exhibiting substantial correlations with a number of HNSCC-related PRO measures including FACT-HN and FHNSI-10. Worsening GP5 was associated with worsening HNCS, FHNSI summary score, and pain intensity. GP5 has promise as a summary indicator of symptom and side effect bother in HNSCC.

Keyphrases

chronic pain
pain management
high intensity
neuropathic pain
big data
artificial intelligence
drug induced